Brendan Frey is the founder of Deep Genomics. Latest round: Series C. Based in Toronto, Canada.
Brendan Frey is the Founder & CEO of Deep Genomics, an AI therapeutics company founded in 2015. Deep Genomics utilizes AI and machine learning to program and prioritize RNA therapeutics for genetic diseases, leveraging a suite of predictive systems known as the AI Workbench.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide